Join to View Full Profile
330 Brookline Ave/9th FlBeth Isreal Deaconess Med.Ctr.Boston, MA 02115
Phone+1 617-667-0843
Dr. Wulf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1997 - 1999
St Elizabeth's Medical CenterResidency, Internal Medicine, 1994 - 1997
Westfalischen Landes University Faculty of MedicineClass of 1987
Certifications & Licensure
MA State Medical License 1996 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer Start of enrollment: 2007 Apr 01
- Trastuzumab and Vinorelbine in Advanced Breast Cancer Start of enrollment: 2010 Nov 01
- Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPatient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses.Jonathan T Lei, Lacey E Dobrolecki, Chen Huang, Ramakrishnan R Srinivasan, Suhas V Vasaikar
Biorxiv. 2025-01-08 - MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial.Mrinal Gounder, Melissa Johnson, Rebecca S Heist, Geoffrey I Shapiro, Sophie Postel-Vinay
Nature Communications. 2025-01-06 - Sensitive Multiplexed MicroRNA Spatial Profiling and Data Classification Framework Applied to Murine Breast Tumors.Omar N Mohd, Yujing J Heng, Lin Wang, Abhishek Thavamani, Erica S Massicott
Analytical Chemistry. 2024-08-06
Journal Articles
- Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast CancerSara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology
Press Mentions
Study Shows Specific Type of Herpes Could Cause Breast CancerAugust 3rd, 2016
Common Virus' Link to Breast Cancer InvestigatedAugust 3rd, 2016
Hub Researchers Uncover Breast Cancer-Mono LinkAugust 3rd, 2016- Join now to see all
Grant Support
- Gender-Affirming Testosterone Therapy on Breast Cancer Risk and Treatment OutcomesBETH ISRAEL DEACONESS MEDICAL CENTER2023–2025
- Role Of The Prolylisomerase PIN1 In OncogenesisNational Cancer Institute2002–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
